EUVIMEDEUVIMED entdecken
CrossrefInfokarte

From Mechanism to Management: The Link Between Inflammatory Bowel Disease and Cardiovascular Disease

Farah Yasmin, Mansoor Ahmed, Taha Bin Iftikhar, Asad ur Rab, Muhammad Saeed Qazi, Muhammad Sohaib Asghar, Mohammed Mahmmoud Fadelallah Eljack, Krutarth Pandya, M. Chadi Alraies

Immunity, Inflammation and Disease · 2026-11 · 14 (11)

DOI: 10.1002/iid3.70570 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Introduction Inflammatory bowel diseases (IBDs) constituting the ulcerative colitis (UC) and Crohn's disease (CD) primarily affect the gastrointestinal tract and have been associated with the development of cardiovascular disease (CVDs). To strengthen this further, the focus of our narrative review is to highlight the clinical significance of understanding this association. Methods We conducted a narrative review to discuss the mechanisms of pathogenesis underlying the link between the management of inflammatory bowel disease and cardiovascular disease. Discussion The pathogenesis of the link likely involves dysregulated immune responses leading to overactivation of pro‐inflammatory cytokines, suggesting a shared inflammatory pathway. Both diseases share common risk factors such as obesity, diabetes, and gender. Genetic factors, including mutations in NOD2 and CDKN2A, also play a role in the overlap between IBDs and CVDs. Despite the recent developments, conventional cardiovascular risk assessment tools may not fully capture the potential elevated cardiovascular threat in IBD patients. Conclusion Thus, proactive investigation with advanced diagnostic tools such as coronary artery calcium (CAC) scoring is crucial in reducing cardiovascular morbidity and mortality in these patients. Nevertheless, future research is needed to further clarify disease activity and its correlations. Clinical Trials Registration NA.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →